SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 48 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $95,037 | -22.4% | 136,059 | 0.0% | 0.02% | -26.7% |
| Q4 2022 | $122,453 | -96.2% | 136,059 | -74.6% | 0.03% | -95.3% |
| Q3 2022 | $3,215,000 | +18.9% | 536,059 | -18.0% | 0.64% | +29.8% |
| Q2 2022 | $2,704,000 | +8.9% | 653,448 | 0.0% | 0.49% | +51.2% |
| Q1 2022 | $2,482,000 | -12.3% | 653,448 | +3.8% | 0.33% | -22.7% |
| Q4 2021 | $2,831,000 | -3.5% | 629,384 | 0.0% | 0.42% | +103.9% |
| Q3 2021 | $2,934,000 | -35.4% | 629,384 | -2.3% | 0.21% | -43.6% |
| Q2 2021 | $4,540,000 | +13.6% | 644,056 | -4.8% | 0.37% | +171.9% |
| Q1 2021 | $3,997,000 | -57.7% | 676,294 | +105.7% | 0.14% | -82.1% |
| Q2 2020 | $9,457,000 | – | 328,824 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |